Semaglutide vs. Tirzepatide in Tampa: Which GLP-1 Weight Loss Program Is Right for You?
Medical weight loss has been transformed by GLP-1 receptor agonists. Semaglutide (the active ingredient in Wegovy and Ozempic) and tirzepatide (Mounjaro, Zepbound) are two of the most studied options available — and patients in Tampa ask us to compare them constantly.
How GLP-1 Medications Work
GLP-1 (glucagon-like peptide-1) is a hormone your gut produces naturally after eating. It signals the pancreas to release insulin, slows gastric emptying (which keeps you fuller for longer), and acts on the brain's appetite centers to reduce hunger and cravings.
GLP-1 medications mimic this hormone, resulting in meaningful reductions in appetite and caloric intake.
Semaglutide: What It Is and How It Works
Semaglutide is a GLP-1 receptor agonist that binds to receptors in the gut, pancreas, and brain, producing reduced appetite and cravings, slower gastric emptying, and better blood sugar regulation. Clinical trials (Wegovy STEP studies) showed an average weight loss of approximately 10–15% of body weight. It is given as a weekly subcutaneous injection, with dosing escalated slowly to minimize GI side effects.
Tirzepatide: The Dual-Receptor Approach
Tirzepatide is a dual agonist — it activates both GLP-1 receptors and GIP (glucose-dependent insulinotropic polypeptide) receptors. GIP is another gut hormone that plays a role in appetite regulation and fat storage. Clinical trials (SURMOUNT) showed tirzepatide producing average weight loss of approximately 15–22% of body weight.
Key Comparison
Both medications require a weekly subcutaneous injection, both have FDA approval for obesity and type 2 diabetes treatment, and both require a medical evaluation and prescription. Tirzepatide targets an additional receptor pathway, and clinical trials have shown higher average weight loss compared to semaglutide. Individual results vary.
Neither medication is a standalone solution — they work best alongside dietary and lifestyle changes.
Who Qualifies for Medical Weight Loss at Roots?
A medical evaluation is required before starting any GLP-1 medication. Generally, candidates are adults with a BMI of 27 or higher with at least one weight-related health condition, or a BMI of 30 or higher.
Payment and Insurance
Roots is a cash-pay practice. Most GLP-1 medications are not covered by standard insurance when prescribed for weight loss. We can provide an itemized superbill for FSA/HSA reimbursement. We also accept Affirm and Cherry Financing.
Book a Weight Loss Consultation in Tampa
Roots is at 1120 E Kennedy Blvd, Unit 125, Channelside, Tampa, FL 33602. Book at rootstampa.com or call 813-706-3578. Same-week consultations are often available.